We invited Minister Bailey to join us for a Conversation That Matters about BC’s strategy to build a vibrant life sciences, biomedical and high-tech base that will help to reshape our future.

Stuart McNish invited Dr. Zandstra to join him for a Conversation that Matters about the role his research has played in finding cures for debilitating chronic diseases and the greater life sciences and biomedical community in Vancouver and British Columbia.

Stuart McNish invited Karl Pringle, the CEO of GenXys Health Care Systems, to join him for a Conversation that Matters about the promise of designer medication and when it might just arrive in your doctor’s office.

We invited Dr Evan Wood and Payton Nyquvest of Numinus to join us for a Conversation That Matters about the positive outcomes psychedelic treatments are offering in therapy.

We invited Carolyn Cross of Ondine Biomedical to join us for a Conversation That Matters about the laser treatment her company has been developing to reduce surgical site infection rates.

For Eaves, there are no limits. “We are going for world domination and it’s all working out nicely.”

In 2000, the world of medicine and research was all aflutter with possibility. The human genome project was about to wrap up and we were promised huge health benefits. That was 16 years ago and so far, reality has come up short of the promised potential.

What if you can capture your healthy immune cells, freeze them and then get them back later if you get cancer or some other life threatening disease? That is the vision of Jeff Schulz, who is spearheading a Vancouver based company that wants to do that.

"It is encouraging. No one has ever done anything quite like this before." That is Dr. Kevin D'Amour's take on a device designed to change lives.